InvestorsHub Logo
Followers 37
Posts 3022
Boards Moderated 0
Alias Born 04/18/2016

Re: jahbvc post# 49391

Thursday, 02/16/2017 8:08:05 AM

Thursday, February 16, 2017 8:08:05 AM

Post# of 203913
The FDA has come through with an approval for Valeant’s psoriasis drug brodalumab. But they’ve hobbled it with a black box safety warning on suicidal ideation and a risk mitigation marketing program that will likely hobble its revenue in an intensely competitive market.

An FDA panel already flagged through the drug – to be sold as Siliq – with many of the experts clearly more interested in obtaining another arrow for their quiver rather than the potential safety issues, which they felt were manageable.